All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-T-2-L408-BZ | HIV h(41BB-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-L408-CZ | HIV h(b2c-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-b2c-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-L408-2BZ | HIV h(CD28-41BB-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-L408-2Z | HIV h(CD28-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-CD28-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-L408-2G | HIV h(CD28-FcεRIγ) CAR, [T] | HIV | DH511 | Human | scFv-CD28-FcεRIγ | Lentiviral | T cell | ||
CAR-T-3-L408-2XZ | HIV h(CD28-OX40-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral | T cell | ||
CAR-T-1-L408-Z | HIV h(CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-L408-4Z | HIV h(CD4-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-CD4-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-L408-4G | HIV h(CD4-FcεRIγ) CAR, [T] | HIV | DH511 | Human | scFv-CD4-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-L408-8Z | HIV h(CD8-CD3ζ) CAR, [T] | HIV | DH511 | Human | scFv-CD8-CD3ζ | Lentiviral | T cell | ||
CAR-T-1-L408-G | HIV h(FcεRIγ) CAR, [T] | HIV | DH511 | Human | scFv-FcεRIγ | Lentiviral | T cell | ||
CAR-T-1-L408-2 | HIV h(CD28) CAR, [T] | HIV | DH511 | Human | scFv-CD28 | Lentiviral | T cell | ||
CAR-ZP138 | Anti-HIV (PGT145) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | PGT145 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP139 | Anti-HIV (PGT145) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | PGT145 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP140 | Anti-HIV (VRC07-523) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | VRC07-523 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP141 | Anti-HIV (VRC07-523) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | VRC07-523 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1782 | Anti-HIV (PGT145) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | PGT145 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1783 | Anti-HIV (PGT145) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | PGT145 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX353 | Anti-HIV (VRC34.05) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | VRC34.05 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX355 | Anti-HIV (N123-VRC34_pI3) h(CD28-CD3ζ) bNAb CAR, pCDCAR1 | Human | N123-VRC34_pI3 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION